Infinium Pharmachem files compliance report for NSE main board migration

Compliance View source PDF Explain this filing

INFINIUM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+10.0%Reaction day

₹266.50

prior close

₹263.00

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.3%+10.3% vs market

On the reaction day the stock moved 10.3 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.8

10m

+0.8

15m

+0.8

30m

+0.8

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

+10.0-0.3+10.3

Next day

+18.2-1.5+19.7

+17.0-1.5+18.5

+15.0-0.2+15.3

+14.8-0.5+15.3

+17.4-3.2+20.7

+18.9-2.2+21.1

15d

+7.3-9.5+16.8

———

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Infinium Pharmachem Limited has submitted its Annual Secretarial Compliance Report for the period April 1, 2026 to September 29, 2026, as part of its migration from the NSE SME Emerge platform to the NSE Main Board. The report by RTBR and Associates confirms full compliance with SEBI regulations, secretarial standards, related party transaction rules, insider trading norms, and disclosure requirements. No penalties or actions by SEBI or stock exchanges were noted.

Likely market impact

Positive for shareholders as main board migration typically improves liquidity, visibility, and attracts institutional investors.